To examine whether mTOR inhibitor sirolimus could suppress mouse Flcn-deficient tumor growth, we treated the above allograft-bearing nude mice with sirolimus at a dose of 7.5 mg/kg every other day. This evidence concerns the gene FLCN and neoplasm.